CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 2,739	$ 54,974
Adjustments to net income (loss):
Depreciation and amortization	316,735	329,699
Deferred income tax expense (benefit)	7,471	12,245
Impairments and other charges	(28)	31,102
Amortization of debt discount and deferred financing costs	3,542	4,388
Bargain purchase gain		(116,499)
Losses (gains) on debt buyback	1,657	(1,914)
Losses (gains) on sale of long-lived assets, net	(124)	(15,831)
Share-based compensation	8,866	8,642
Foreign currency transaction losses (gains), net	2,001	2,087
Mark-to-market (gain) loss on warrants	(672)	(7,399)
Other	3	2,232
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(48,133)	(15,981)
Inventory	6,942	20,357
Other current assets	(31,385)	(34,887)
Other long-term assets	3,556	(843)
Trade accounts payable and accrued liabilities	(7,442)	(23,682)
Income taxes payable	(2,238)	(6,792)
Other long-term liabilities	(14,909)	(2,353)
Net cash provided by (used for) operating activities	248,581	239,545
Cash flows from investing activities:
Purchases of investments	(6,990)	(1,782)
Cash acquired in stock based business combination, net of cash paid		84,429
Capital expenditures	(290,566)	(343,865)
Proceeds from sales of assets and insurance claims	6,108	42,855
Other	(880)	7,500
Net cash (used for) provided by investing activities	(292,328)	(210,863)
Cash flows from financing activities:
Reduction in debt	(379,146)	(190,270)
Proceeds from revolving credit facilities		318,000
Reduction in revolving credit facilities		(140,000)
Payment of dividend to former Parker shareholders		(6,052)
Payments for employee taxes on net settlement of equity awards	(3,598)	(2,151)
Distributions to noncontrolling interest	(2,401)	(875)
Other	5
Net cash (used for) provided by financing activities	(385,140)	(21,348)
Effect of exchange rate changes on cash and cash equivalents	(2,052)	(2,203)
Net increase (decrease) in cash and cash equivalents and restricted cash	(430,939)	5,131
Cash and cash equivalents and restricted cash, beginning of period	942,844	722,960
Cash and cash equivalents and restricted cash, end of period	511,905	728,091
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	940,707	389,652
Restricted cash, beginning of period	2,137	333,308
Cash and cash equivalents and restricted cash, beginning of period	942,844	722,960
Cash and cash equivalents, end of period	509,782	387,321
Restricted cash, end of period	$ 2,123	$ 340,770
Restricted cash, Balance Sheet location	Other current assets, Other long-term assets	Other current assets, Other long-term assets
Cash and cash equivalents and restricted cash, end of period	$ 511,905	$ 728,091